헬스케어 공급망 BPO 시장 규모, 점유율, 동향 분석 보고서 : 페이어 서비스별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Healthcare Supply Chain BPO Market Size, Share & Trends Analysis Report By Payer Service (Order Management),By End-use (Biotechnology & Pharmaceutical Companies, Medical Device Companies),By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,242,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,627,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,398,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

헬스케어 공급망 BPO 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계 헬스케어 공급망 BPO 시장 규모는 2025-2030년에 걸쳐 CAGR 5.5%로 성장할 것으로 예상되며, 2030년에는 36억 8,000만 달러에 이를 것으로 추정됩니다.

효율적인 재고 관리 시스템에 대한 수요 증가와 비용 절감 및 공급망 품질 향상을 위한 의료 제공업체의 노력이 시장 성장을 가속할 것으로 예측됩니다.

헬스케어 공급망의 비즈니스 프로세스 아웃소싱(BPO)은 비용 절감, 트랜잭션 및 활성 처리를 위해 부대 기능을 제3자 기관에 아웃소싱함으로써 비즈니스를 확대하기 위해 의료 산업이 채택하는 전략입니다. 시장 성장을 촉진하는 주요 요인은 의료 서비스 제공 비용 감소 압력 증가, 심혈관 질환의 유병률 증가, 경험 풍부한 의료 BPO 서비스 제공업체의 존재감 증가에 따라, 아웃소싱 서비스는 의료 IT 산업에 다양한 비즈니스 기회를 가져올 것으로 기대되고 있습니다.

북미가 가장 큰 점유율을 차지하고 있으며 예측 기간 동안에도 리드를 유지할 것으로 보입니다. 해외 의료 공급망 비즈니스 프로세스 아웃소싱의 채택이 증가하고 비용 영향에 대한 인식이 높아지면서 이 지역 시장을 견인할 것으로 예측됩니다. 또, 제약 부문에 있어서의 기술 개발의 진전, 신흥국에서의 의료 IT 서비스에 대한 수요 증가가 이 지역 시장 성장을 가속할 것으로 예측됩니다.

헬스케어 공급망 BPO 시장 보고서 하이라이트

• 결제 서비스를 기반으로 한 주문 관리 부문은 2024년에 36.1%의 최대 수익 점유율을 차지했으며, 재고의 최적화, 수주 정밀도의 향상, 시기 적절한 배송의 확보에 있어서 중요한 역할을 완수했습니다.
• 제조 관리 결제 서비스 부문은 합리화된 생산·유통 프로세스에 대한 수요 증가에 견인되어 예측 기간 중에 가장 빠른 CAGR 6.1%로 성장할 전망입니다.
• 최종 용도별로는 바이오테크놀러지와 제약기업이 2024년에 가장 큰 수익 점유율을 차지했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 헬스케어 공급망 BPO 시장의 변수, 동향, 범위

• 시장 계통의 전망
  • 상위 시장 전망
  • 관련, 보조시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 헬스케어 공급망 BPO 시장 분석 툴
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 헬스케어 공급망 BPO 시장 : 페이어 서비스별, 추정·동향 분석

• 지불 서비스 부문 대시보드
• 헬스케어 공급망 BPO 시장 : 페이어 서비스 변동 분석
• 세계의 헬스케어 공급망 BPO 시장 규모와 동향 분석(페이어 서비스별, 2018-2030년)
• 주문 관리
• 재고 관리
• 수송 관리
• 제조관리
• 지속가능성 서비스

제5장 헬스케어 공급망 BPO 시장 : 최종 용도별, 추정·동향 분석

• 최종 용도 부문 대시보드
• 헬스케어 공급망 BPO 시장 : 최종 용도 변동 분석
• 세계의 헬스케어 공급망 BPO 시장 규모와 동향 분석(최종 용도별, 2018-2030년)
• 생명공학과 제약회사
• 의료기기 기업
• 기타

제6장 헬스케어 공급망 BPO 시장 : 지역별, 추정·동향 분석

• 지역별 시장 대시보드
• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 건강 관리 공급 체인 BPO 시장 : 주요 포인트
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
• 기업/경쟁의 분류
• 벤더 상황
  • Key Company 히트맵 분석, 2024년
• 기업 프로파일
  • Firstsource
  • GeBBS(Gebbs Healthcare Solutions)
  • WNS(Holdings) Ltd.
  • Xerox Corporation
  • SAP SE
  • Tecsys Inc.
  • MCKESSON CORPORATION
  • Cognizant
  • Accenture
  • Genpact
  • TATA Consultancy Services Limited

SHW

영문 목차

영문목차

Healthcare Supply Chain BPO Market Growth & Trends:

The global healthcare supply chain BPO market size is estimated to reach USD 3.68 billion by 2030, registering a CAGR of 5.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising demand for an efficient inventory management system and increasing efforts of healthcare providers to reduce costs and improve the quality of the supply chain are anticipated to propel the market growth.

Healthcare supply chain business process outsourcing (BPO) is a strategy adopted by the healthcare industries to increase their business by outsourcing their ancillary functions to third party organizations in order to reduce cost, transaction, and active processing. The major factors fueling the market growth are rising pressure to decrease the healthcare delivery cost, increasing prevalence of cardiovascular diseases, and the growing presence of experienced healthcare BPO service providers. With the increasing demand for healthcare, the outsourcing services are expected to provide various opportunities for the healthcare IT industries to poach on. Additionally, an increasing number of people pursuing insurance and consolidation of the healthcare system are the major factors fueling market growth.

North America held the largest share and is expected to maintain its lead over the forecast period. Increasing adoption of offshore healthcare supply chain business process outsourcing and raising awareness with regards to cost implications are expected to drive the market in the region. In addition, increased technological development in the pharmaceutical sector and growing demand for healthcare IT services in the region are anticipated to propel market growth in the region.

Healthcare Supply Chain BPO Market Report Highlights:

• Based on payer service, the order management segment held the largest revenue share of 36.1% in 2024, driven by its critical role in optimizing inventory, improving order accuracy, and ensuring timely deliveries.
• The manufacturing management payer service segment is anticipated to grow at a fastest CAGR of 6.1% over the forecast period, driven by the increasing demand for streamlined production and distribution processes.
• By End-use, the biotechnology and pharmaceutical companies segment held the largest revenue share in 2024, attributed to their complex supply chains, regulatory requirements, and the need for efficient distribution of sensitive products.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Payer Service
  • 1.2.2. End Use
  • 1.2.3. Regional Scope
  • 1.2.4. Estimates and Forecasts Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Payer Service Outlook
  • 2.2.2. End Use Outlook
  • 2.2.3. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Healthcare Supply Chain BPO Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Healthcare Supply Chain BPO Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Technological Landscape
    • 3.3.2.3. Economic Landscape

Chapter 4. Healthcare Supply Chain BPO Market: Payer Service Estimates & Trend Analysis

• 4.1. Payer Service Segment Dashboard
• 4.2. Healthcare Supply Chain BPO Market: Payer Service Movement Analysis
• 4.3. Global Healthcare Supply Chain BPO Market Size & Trend Analysis, By Payer Service, 2018 to 2030 (USD Million)
• 4.4. Order Management
  • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.5. Inventory Management
  • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.6. Transport Management
  • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.7. Manufacturing Management
  • 4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.8. Sustainability Services
  • 4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Healthcare Supply Chain BPO Market: End Use Estimates & Trend Analysis

• 5.1. End Use Segment Dashboard
• 5.2. Healthcare Supply Chain BPO Market: End Use Movement Analysis
• 5.3. Global Healthcare Supply Chain BPO Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
• 5.4. Biotechnology and Pharmaceutical Companies
  • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.5. Medical Device Companies
  • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Healthcare Supply Chain BPO Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Dashboard
• 6.2. Regional Market Share Analysis, 2024 & 2030
• 6.3. Healthcare Supply Chain BPO Market by Region: Key Takeaways
• 6.4. North America
  • 6.4.1. U.S.
    • 6.4.1.1. Key Country Dynamics
    • 6.4.1.2. Regulatory Framework/ Reimbursement Structure
    • 6.4.1.3. Competitive Scenario
    • 6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Canada
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.4.2.3. Competitive Scenario
    • 6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Mexico
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.4.3.3. Competitive Scenario
    • 6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. U.K.
    • 6.5.1.1. Key Country Dynamics
    • 6.5.1.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.1.3. Competitive Scenario
    • 6.5.1.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Germany
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.2.3. Competitive Scenario
    • 6.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.3. France
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Italy
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.4.3. Competitive Scenario
    • 6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.5. Spain
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.5.3. Competitive Scenario
    • 6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.6. Denmark
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.6.3. Competitive Scenario
    • 6.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.7. Sweden
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.7.3. Competitive Scenario
    • 6.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.8. Norway
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework/ Reimbursement Structure
    • 6.5.8.3. Competitive Scenario
    • 6.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Japan
    • 6.6.1.1. Key Country Dynamics
    • 6.6.1.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.1.3. Competitive Scenario
    • 6.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.2. China
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.2.3. Competitive Scenario
    • 6.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.3. India
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Australia
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Thailand
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.5.3. Competitive Scenario
    • 6.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.6. South Korea
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework/ Reimbursement Structure
    • 6.6.6.3. Competitive Scenario
    • 6.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.7.2.3. Competitive Scenario
    • 6.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.7.3.3. Competitive Scenario
    • 6.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.8. Middle East and Africa
  • 6.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework/ Reimbursement Structure
    • 6.8.2.3. Competitive Scenario
    • 6.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework/ Reimbursement Structure
    • 6.8.3.3. Competitive Scenario
    • 6.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework/ Reimbursement Structure
    • 6.8.4.3. Competitive Scenario
    • 6.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Framework/ Reimbursement Structure
    • 6.8.5.3. Competitive Scenario
    • 6.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/ Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. Key Company Heat Map Analysis, 2024
• 7.4. Company Profiles
  • 7.4.1. Firstsource
    • 7.4.1.1. Company Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. GeBBS (Gebbs Healthcare Solutions)
    • 7.4.2.1. Company Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. WNS (Holdings) Ltd.
    • 7.4.3.1. Company Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Xerox Corporation
    • 7.4.4.1. Company Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. SAP SE
    • 7.4.5.1. Company Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. Tecsys Inc.
    • 7.4.6.1. Company Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. MCKESSON CORPORATION
    • 7.4.7.1. Company Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. Cognizant
    • 7.4.8.1. Company Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Accenture
    • 7.4.9.1. Company Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. Genpact
    • 7.4.10.1. Company Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Strategic Initiatives
  • 7.4.11. TATA Consultancy Services Limited
    • 7.4.11.1. Company Overview
    • 7.4.11.2. Financial Performance
    • 7.4.11.3. Product Benchmarking
    • 7.4.11.4. Strategic Initiatives

관련자료